Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream

  1. Home

  • Saturday, Nov 16th
    10:30 AM – 11:30 AM Eastern Time
    16S23: Unmet Needs in Sjögren's Syndrome: Recognition, Prevention, and Management
    Location: Room 206
    Moderator: R. Scofield, MD – Oklahoma Medical Research Foundation
    Moderator: Blake M. Warner, PhD;MPH;DDS – National Institutes of Health
    Sjögren’s syndrome
     CME 1 hours
  • Saturday, Nov 16th
    10:30 AM – 10:45 AM Eastern Time
    Best Practices for the Management of Sicca
    Location: Room 206
    Speaker: Leslie Laing, PhD, BSc, MSc, DDS – Faculty of Dentistry University of Toronto; Sjogren's Society of Canada; Toronto Public Health Dental and Oral Care Clinics
    Sjögren’s syndrome
  • Saturday, Nov 16th
    10:45 AM – 11:00 AM Eastern Time
    Nuts and Bolts of Glandular Pathology in Sjögren's Syndrome
    Location: Room 206
    Speaker: Scott Lieberman, MD,PhD – University of Iowa
    Sjögren’s syndrome
  • Saturday, Nov 16th
    11:00 AM – 11:15 AM Eastern Time
    Rheumatology Perspective of Pulmonary and Renal Manifestations of Sjögren's Syndrome
    Location: Room 206
    Speaker: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
    Sjögren’s syndrome
  • Saturday, Nov 16th
    11:15 AM – 11:30 AM Eastern Time
    Panel Q&A Discussion
    Location: Room 206
    Panelist: Leslie Laing, PhD, BSc, MSc, DDS – Faculty of Dentistry University of Toronto; Sjogren's Society of Canada; Toronto Public Health Dental and Oral Care Clinics
    Panelist: Scott Lieberman, MD,PhD – University of Iowa
    Panelist: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 11:30 AM Eastern Time
    17S22: Novel Imaging and Therapeutics in Sjögren's Syndrome
    Location: Room 150AB
    Moderator: Dana DiRenzo, MD;RhMSUS;MHS – University of Pennsylvania
    Moderator: Howard Yang, MD, RhMSUS – UCLA Medical Center
    Sjögren’s syndrome
     CME 1 hours
  • Sunday, Nov 17th
    10:30 AM – 10:50 AM Eastern Time
    Challenges for Disease -Modifying Therapy in Sjogren's Disease
    Location: Room 150AB
    Speaker: Alan Baer, MD,FACP,MACR – Johns Hopkins University School of Medicine
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:50 AM – 11:10 AM Eastern Time
    Novel Imaging to Diagnose Sjögren's Syndrome: Cutting-Edge Techniques
    Location: Room 150AB
    Speaker: Alojzija Hocevar, MD,PhD – University Medical Center Ljubljana
    Sjögren’s syndrome
  • Sunday, Nov 17th
    11:10 AM – 11:30 AM Eastern Time
    Clinical Trial Update in Sjögren's Syndrome
    Location: Room 150AB
    Speaker: George A. W. Bruyn, MD,PhD,MACR – Reumakliniek Lelystad
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    Sjögren's Syndrome – Basic & Clinical Science Poster I
    Sjögren’s syndrome
     CME 0 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1406: Development and Functional Characterization of Salivary Gland Organoids to Investigate Sjögren’s Disease
    Abstract Poster Presenter: Gaetane Nocturne, MD;PhD – Service de Rhumatologie, Hôpital Bicêtre, AP-HP
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1408: Color Doppler Ultrasound Is a Reliable Method for Imaging the Lacrimal Glands in Patients with Suspected Sjögren’s Disease
    Abstract Poster Presenter: Sarah Pringle, PhD (she/her/hers) – University Medical Center Groningen
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1410: Using Social Listening to Understand the Patient Voice: The Daily Impacts of Sjögren’s Disease
    Abstract Poster Presenter: Maria Picone, BA – TREND Community
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1411: Impact of Patient and Physician Alignment on Sjögren’s Disease Severity, a Real-World Survey on Patients’ Clinical Outcomes and Health-Related Quality of Life
    Abstract Poster Presenter: Jessica Marvel, MPH – Novartis
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1412: Survival and Predictive Markers of Prognosis in Patients with Cancer Occurrence After Sjögren Syndrome: A Long-term Observational Study
    Abstract Poster Presenter: Xiangyi Shen, MD – Tsinghua University
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1413: Pilot Trial of Ustekinumab for Primary Sjogren’s Syndrome
    Abstract Poster Presenter: Ummara Shah, MD (she/her/hers) – University of Rochester
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1414: Evidence-Based Guidelines for Sjögren’s Disease Peripheral Nervous System Manifestations
    Abstract Poster Presenter: Matt Makara, MPH – Sjogren's Foundation
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1415: Metformin Improves Salivary Gland Infiltration and Objective Measures of Dry Eyes in Sjögren’s Disease: A Retrospective Observational Study
    Abstract Poster Presenter: Astrid Rasmussen, MD, PhD – Oklahoma Medical Research Foundation
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1416: Ultrasound (US)-guided Core-needle Biopsy (CNB) of the Non-swollen Parotid Gland: A Feasible and Well-tolerated Technique for Diagnosing and Stratifying Sjögren's Disease (SjD)
    Abstract Poster Presenter: isabelle peene, MD,PhD – University Hospital Ghent
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1417: Organ-Specific Autoimmune Involvement in Primary Sjögren’s Disease
    Abstract Poster Presenter: Gabriela Hernandez-Molina, MD, MS – Instituto Nacional de Ciencias Medicas y Nutricion
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1418: Soluble Immune Checkpoint Molecules as Biomarkers for Extraglandular Sjögren's Disease
    Abstract Poster Presenter: Arman Aue, MD – Charité Universitätsmedizin Berlin
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1419: Antiphospholipid Antibodies and Hypercoagulable Events in Patients with Sjogren’s Syndrome
    Abstract Poster Presenter: Katelyn Kaufman, DO – University of Miami at Holy Cross Hospital
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1420: Alignment Between Rheumatology and Neurology of Nomenclature for Peripheral Nervous System Neuropathies
    Abstract Poster Presenter: Ghaith Noaiseh, MD – University of Kansas Medical Center
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1421: Differential Impact of B-cell Targeted Monotherapy and Combination Regimen on the Peripheral Blood Transcriptome of Adults with Active Sjögren Disease
    Abstract Poster Presenter: Coziana Ciurtin, MD, PhD, FRCP – University College London
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1422: Evaluation of Salivary Gland Focus Score in Sjogren's Disease Using Deep Learning: A Step Towards Tissue Biomarker Discovery
    Abstract Poster Presenter: Andreas Goules – Dept. of Pathophysiology, School of Medicine, University of Athens
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1423: An Observational Analytical Study on HCV Patients with Sicca Manifestations Before and After Direct-Acting Antivirals in Comparison with Sjogren's Disease; Infection versus Autoimmunity
    Abstract Poster Presenter: Mohamed Tharwat Hegazy, MD – Faculty of Medicine, Cairo University
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1424: Associations of Human Leukocyte Antigens (HLA) Class II with Interstitial Lung Disease (ILD) in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs). A Prospective Study in Sequential Patients with SARD-ILD
    Abstract Poster Presenter: Andreas Goules – Dept. of Pathophysiology, School of Medicine, University of Athens
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1425: Sjögren's Syndrome and Interstitial Lung Disease: Experience in a Collaborative Rheumatology-Pulmonology Clinic
    Abstract Poster Presenter: Sonia Jiménez Barrios, MD (she/her/hers) – Hospital Universitario Ramón y Cajal
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1426: Single Cell RNA-Seq Characterization of Circulating Immune Cells in Sjogren's Syndrome: Comparison to SLE and Rheumatoid Arhtritis
    Abstract Poster Presenter: Alejandro Gómez Gómez, PhD – Hospital Universitari Vall d'Hebron
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1427: Observed and Simulated Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Fully Human FcRn Blocking Monoclonal Antibody, in Adults with Sjögren’s Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study
    Abstract Poster Presenter: Sophia G. Liva, PhD – Janssen Research & Development, LLC, a Johnson & Johnson Company
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1428: A Post-hoc Analysis of Two Phase 2 Randomized Controlled Trials in Patients with Active Sjogren’s Disease Exploring the Novel Composite Endpoint Sjögren’s Tool for Assessing Response (STAR)
    Abstract Poster Presenter: Peter Gergely, MD, PhD (he/him/his) – Novartis Pharma
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1429: Association of Bone Erosion and Microarchitecture with Disease Activity and Damage in Sjögren's Disease
    Abstract Poster Presenter: Andre Franco, MD (he/him/his) – University of São Paulo
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1430: C57BL/6.NOD-Aec1Aec2 Mice Recapitulate Sjögren’s Serology Better Than NOD.B10Sn-H2b Models and JAK Inhibitor Treatment Improves Immunoglobulins and Salivary Gland Inflammation but Not Salivary Flow in Sjögren’s Mice
    Abstract Poster Presenter: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1431: Computational Systems Biology Approach to Unveil Molecular Interactions in Sjogren's Disease Pathogenesis
    Abstract Poster Presenter: Gaetane Nocturne, MD;PhD – Service de Rhumatologie, Hôpital Bicêtre, AP-HP
    Sjögren’s syndrome
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1432: Diagnostic Performance of Mayor Salivary Gland Ultrasound for Diagnosis of Sjögren's Syndrome in Routine Clinical Practice
    Abstract Poster Presenter: Carmen Raya-Santos, Sr, MD (she/her/hers) – Hospital Marina Baixa
    Sjögren’s syndrome
  • Sunday, Nov 17th
    3:00 PM – 4:30 PM Eastern Time
    17S44: Where the Rubber Meets the Road: Exploring the Epithelial-Immune Cell Interplay Underlying Sjögren's Syndrome
    Location: Room 144ABC
    Moderator: Teresa Tarrant, MD – Duke University
    Moderator: Blake M. Warner, PhD;MPH;DDS – National Institutes of Health
    Sjögren’s syndrome
     CME 1.5 hours
  • Sunday, Nov 17th
    3:00 PM – 3:30 PM Eastern Time
    Unbiased Antigen Discovery in Sjögren's Disease
    Location: Room 144ABC
    Speaker: Mohammad Haj Dezfulian, PhD – Harvard Medical School
    Sjögren’s syndrome
  • Sunday, Nov 17th
    3:30 PM – 4:00 PM Eastern Time
    JAK-STAT Signaling and Interferon-Driven Immune Activation in Sjögren's Disease
    Location: Room 144ABC
    Speaker: Sarthak Gupta, MD – NIAMS, NIH
    Sjögren’s syndrome
  • Sunday, Nov 17th
    4:00 PM – 4:30 PM Eastern Time
    Epithelial–immune Cell Interplay in Primary Sjögren Syndrome Salivary Gland Pathogenesis
    Location: Room 144ABC
    Speaker: Gwenny Verstappen, Ph.D., PharmD – University Medical Center Groningen
    Sjögren’s syndrome
  • Monday, Nov 18th
    7:30 AM – 8:30 AM Eastern Time
    MTP18A: Meet the Professor: Sjögren's Syndrome
    Location: Room 154B
    Seminar Presenter: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
    Sjögren’s syndrome
     CME 1 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    Sjögren's Syndrome – Basic & Clinical Science Poster II
    Sjögren’s syndrome
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2287: Hydroxychloroquine and the Risk of Lymphoma Progression in Sjogren’s Disease: A Retrospective Case Control Study
    Abstract Poster Presenter: Christine Xue, MD – UC San Diego
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2288: Interferon Gamma Signaling Is Associated with Development of Extraglandular Manifestations in Sjögren’s Disease
    Abstract Poster Presenter: Hiroyuki Nakamura, MD, PhD – Sapporo Medical University
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2289: Associations Between Protein Quantitative Trait Loci and Risk of Primary Sjögren’s Syndrome: A Mendelian Randomization Study
    Abstract Poster Presenter: Benjamin Zuckerman, MBBS, BSc – Guy's and St Thomas' NHS Foundation Trust
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2290: Umbilical Cord-derived Mesenchymal Stem Cells Suppress Sjogren’s Syndrome Pathology
    Abstract Poster Presenter: Yukitomo Hagiwara, MD – Juntendo University
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2291: The Relationship of the ESSDAI to Health-Related Quality of Life in People Living with Sjogren’s Disease
    Abstract Poster Presenter: Dana DiRenzo, MD;RhMSUS;MHS – University of Pennsylvania
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2292: Fibroblasts with High Expression of CD74 Promote Lymphocytes Infiltration in Salivary Gland in Sjӧgren's Disease
    Abstract Poster Presenter: Yuan Liu, n/a – xiamen university
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2293: Altered Expression of the MicroRNA Biogenesis Machinery Components Correlates with Inflammatory Parameters in Salivary Glands of Patient with Sjögren’s Disease
    Abstract Poster Presenter: Sergio Aguilera, MD – Clinica Indisa
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2294: Pharmacodynamic Effects of Nipocalimab on Disease Biomarkers in Patients with Moderate-to-Severe Active Sjögren's Disease: Results from a Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2 Study
    Abstract Poster Presenter: Kathy Sivils, PhD – Johnson & Johnson Innovative Medicine
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2295: Association of Early Markers in Patients with Sjögren’s Syndrome in a Diverse Academic Cohort
    Abstract Poster Presenter: Danielle Henry, MBBS (she/her/hers) – University of Miami at Holy Cross Health
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2296: The Value of Ultrasound to Follow Glandular Disease in Sjogren's Disease Patients
    Abstract Poster Presenter: Katja Perdan Pirkmajer, MD, PhD (she/her/hers) – University Medical Centre Ljubljana
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2297: Mortality and Its Predictor Variables in Patients with Sjögren Disease: Data from SjögrenSER-Pros Prospective Registry
    Abstract Poster Presenter: Olga Rusinovich, MD – Puerta de Hierro Majadahonda University Hospital
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2298: Fibroblast-driven Ttek Activation May Drive Acinar Cell Dysfunction in Sjögren’s Disease, Prior to Lymphocytic Infiltration
    Abstract Poster Presenter: Sarah Pringle, PhD (she/her/hers) – University Medical Center Groningen
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2299: Clinical and Serological Characteristics of Sjögren’s Disease-related Lymphocytic Interstitial Pneumonia: A Large Multicenter Study
    Abstract Poster Presenter: Gaetano La Rocca, MD – University of Pisa, Rheumatology Unit
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2300: Activation of Tissue-Resident T Cells in Sjögren's Disease with Human Salivary Organoids
    Abstract Poster Presenter: Brandon Law, MD – Massachusetts General Hospital
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2301: The Added Value of anti-Ro52 Antibody Titer in the Diagnosis of Sjögren’s Disease
    Abstract Poster Presenter: Chiara Baldini, MD, PhD – University of Pisa
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2302: A Specific Molecular Profiling of Secreted Rheumatoid Factors in Sjögren’ S Disease Patients with Lymphoma
    Abstract Poster Presenter: Gaetane Nocturne, MD,PhD – University Paris Saclay
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2303: Type I Interferon Signature Drives Phenotypic Clusters of Sjögren's Disease and Can Predict Systemic Evolution Among the "B-cell Active with Low Symptoms" Subgroup
    Abstract Poster Presenter: Gaetane Nocturne, MD;PhD – Service de Rhumatologie, Hôpital Bicêtre, AP-HP
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2304: Differential Diagnosis of Sjogren’s vs Non-Sjogren’s Dry Eye
    Abstract Poster Presenter: Pineal Bareamichael, MD, MPH, MBA – Johns Hopkins Bloomberg School of Public Health
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2305: Anti-Ku Positivity in Primary Sjögren’s Disease Is Associated with a More Systemic Active Disease
    Abstract Poster Presenter: Raphaele SEROR, MD, PhD – Paris-Sud University Hospital
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2306: Deconstruction and Reconstruction of Sjögren’s Disease: AMP®-AIM Partnership
    Abstract Poster Presenter: Astrid Rasmussen, MD, PhD – Oklahoma Medical Research Foundation
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2307: Deep Spatial Profiling Unveils Dominant Double Negative B Cells in Severe Forms of Sjögren's Syndrome
    Abstract Poster Presenter: Loukas Chatzis, MD – Pathophysiology Department, Athens School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2308: Characterization of Damage in a Primary Sjogren's Syndrome Cohort
    Abstract Poster Presenter: Ana Mafalda Abrantes, MD – Unidade Local de Saúde Santa Maria
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2309: Damage Accrual Predicts the Development of Lymphoma in Primary Sjogren’s Syndrome
    Abstract Poster Presenter: Ana Mafalda Abrantes, MD – Unidade Local de Saúde Santa Maria
    Sjögren’s syndrome
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2310: Prospective Evaluation of Pulmonary Involvement in Patients with Primary Sjögren’s Disease, Using Pulmonary Function Tests and High Resolution Computed Tomography, Reveals High Prevalence of Subclinical Interstitial Lung Disease, Along with Small Airways Disease
    Abstract Poster Presenter: Andreas Goules – Dept. of Pathophysiology, School of Medicine, University of Athens
    Sjögren’s syndrome
  • Monday, Nov 18th
    11:30 AM – 12:30 PM Eastern Time
    MTP18B: Meet the Professor: Sjögren's Syndrome
    Location: Room 154B
    Seminar Presenter: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
    Sjögren’s syndrome
     CME 1 hours
  • Monday, Nov 18th
    3:00 PM – 4:30 PM Eastern Time
    18M67: Abstracts: Sjögren's Syndrome – Basic & Clinical Science
    Location: Room 103AB
    Abstract Moderator: Hanna Zembrzuska, MD – University of Iowa Hospitals and Clinics
    Abstract Moderator: Valeria Manfrè, MD – Division of Rheumatology, Department of Medicine, University of Udine, Italy; Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, WI
    Sjögren’s syndrome
     CME 0 hours
  • Monday, Nov 18th
    3:00 PM – 3:15 PM Eastern Time
    2629: Deciphering Salivary Gland Inflammation in Sjögren's Syndrome Reveals Shared and Autoantibody-Specific Immune Cell Heterogeneity
    Location: Room 103AB
    Presenting Author: Jun Inamo, MD, PhD – University of Colorado School of Medicine
    Sjögren’s syndrome
  • Monday, Nov 18th
    3:15 PM – 3:30 PM Eastern Time
    2630: Identification of Molecular Biomarkers for Sjögren's Disease Stratification via a Deep Learning Foundation Model Dedicated to Immune-Mediated and Inflammatory Disease
    Location: Room 103AB
    Presenting Author: Vincent Bouget, MSc – Scienta Lab
    Sjögren’s syndrome
  • Monday, Nov 18th
    3:30 PM – 3:45 PM Eastern Time
    2631: Risk of Atherosclerotic Cardiovascular Events and Venous Thromboembolism in People with Primary Sjögren’s Syndrome: A Danish Cohort Study
    Location: Room 103AB
    Presenting Author: Pierre Loiseau, MD – CHU Amiens-Picardie
    Sjögren’s syndrome
  • Monday, Nov 18th
    3:45 PM – 4:00 PM Eastern Time
    2632: Genetically-engineered Ro-specific Regulatory T Cells to Treat Primary Sjögren’s Disease
    Location: Room 103AB
    Presenting Author: Zhi Feng Sherman Lim, PhD – Monash University
    Sjögren’s syndrome
  • Monday, Nov 18th
    4:00 PM – 4:15 PM Eastern Time
    2633: Multicenter Validation of a Machine Learning Foundation Model to Diagnose Sjögren’s Disease and Identify Histological Biomarkers for Disease Stratification
    Location: Room 103AB
    Presenting Author: Vincent Bouget, MSc – Scienta Lab
    Sjögren’s syndrome
  • Monday, Nov 18th
    4:15 PM – 4:30 PM Eastern Time
    2634: Transcriptomic Stratification Predicts Response to Rituximab, Abatacept or the Association of Hydroxychloroquine and Leflunomide in 3 Randomized Controlled Clinical Trials in Sjögren’s Disease
    Location: Room 103AB
    Presenting Author: Baptiste Chevet, MD, MSc (he/him/his) – University Hospital of Brest
    Sjögren’s syndrome